Then this inhibitory effect was amplified when cells were pretreated with Grb2 loss (Figure 5C), indicating that the interaction between ECT2 and Grb2 leads to increased EGFR and promotes EMT of pancreatic cancer cells. This evidence concerns the gene ECT2 and familial pancreatic carcinoma.